Invesco Ltd. - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 78 filers reported holding CUE BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$40,586
-37.0%
17,6460.0%0.00%
Q2 2023$64,408
+7.3%
17,646
+41.9%
0.00%
Q1 2022$60,000
-57.7%
12,437
-1.1%
0.00%
Q4 2021$142,000
-23.7%
12,581
-1.4%
0.00%
Q3 2021$186,000
-70.1%
12,763
-71.0%
0.00%
Q1 2020$623,000
-33.5%
43,944
-25.5%
0.00%
Q4 2019$937,00058,9940.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
Bleichroeder LP 755,028$1,736,5640.43%
Monaco Asset Management SAM 359,739$827,4000.24%
Slate Path Capital LP 2,402,455$5,525,6470.15%
SANDERS MORRIS HARRIS LLC 346,212$713,4260.15%
ADVISORY RESEARCH INC 257,225$591,6180.08%
Robertson Stephens Wealth Management, LLC 478,500$1,100,5500.07%
Annandale Capital, LLC 65,000$1500.04%
Good Life Advisors, LLC 112,000$257,6000.03%
CARLSON CAPITAL L P 135,000$310,5000.02%
CORNERCAP INVESTMENT COUNSEL INC 57,888$133,1420.02%
View complete list of CUE BIOPHARMA INC shareholders